Table 1.
Patient Clinical Characteristics and Demographics
| Characteristics | Total Allogeneic HCT Patients (n = 738) |
|---|---|
| Age at HCT, median (range), yr | 51 (0–73) |
| Follow-up time, median (95% CI), wk* | 121 (93–157) |
| Sex, n (%) | |
| M | 438 (59) |
| F | 300 (41) |
| Indication, n (%) | |
| Malignant | 623 (84) |
| Nonmalignant | 115 (16) |
| HLA disparity, n (%) | |
| Matched | 583 (79) |
| Mismatched | 155 (21) |
| Donor relationship, n (%) | |
| Related | 355 (48) |
| Unrelated | 383 (52) |
| Number of HCT, n (%) | |
| First | 652 (88) |
| Second/third | 86 (12) |
| Conditioning by irradiation, n (%) | |
| TBI-based | 185 (25) |
| Chemotherapy-based | 553 (75) |
| Conditioning by intensity, n (%) | |
| Myeloablative | 518 (70) |
| Nonmyeloablative | 220 (30) |
| Graft source, n (%) | |
| PB | 600 (81) |
| BM | 87 (12) |
| CB | 51 (7) |
Definition of abbreviations: BM = bone marrow; CB = umbilical cord blood; CI = confidence interval; HCT = hematopoietic cell transplantation; PB = peripheral blood; TBI = total body irradiation.
Values are indicated as the number (percentage), except age at HCT and follow-up time as specified.
*
Median follow-up time and the corresponding 95% CI was estimated by a Kaplan-Meier method.